Drug Trial Radar · NCT06268574
Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML
Last checked: Nov 19, 2026Latest source record: Sep 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
62
Actual
Start
Jan 23, 2024
Primary completion
Jun 30, 2025
Study completion Sep 5, 2025
Sponsor
- Lead sponsor
- Ryvu Therapeutics SAIndustry
- Sponsor type
- Industry
- First posted
- Feb 20, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this study is to assess the safety, tolerability, anti-tumor activity (efficacy), pharmacokinetics (PK), and pharmacodynamics (PD) of the agent RVU120 when administered to adult patients with relapsed or refractory acute myeloid leukemia (AML) or relapsed or progressing high-risk myelodysplastic syndrome (HR-MDS) and who have no alternative therapies available. The study consists of two parts. Part 1 will assess the safety and tolerability of the dosages given and the level of anti-tumor activity or clinical response. Based on the results from part 1 the study will continue to enrol patient into Part 2 which will continue to evaluate safety and tolerability and anti-tumor activity in a larger number of patients.
Conditions
- Acute Myeloid Leukemia (AML)
- High-risk Myelodysplastic Syndrome
Interventions
RVU120Drug
RVU120 is a potent, selective inhibitor of CDK8 and its paralog CDK19
Primary outcomes
What the sponsor says the trial is designed to measure.
- Complete Remission (CR), with and without measurable residual disease (MRD)Time frame: 12 months
Locations
41 sites in 4 countries. Site status is shown where the registry gives one.
Centre Hospitalier Universitaire Grenoble Alpes
La Tronche, France
Centre Hospitalier Le Mans
Le Mans, France
Centre Hospitalier Universitaire de Lille (CHU Lille)
Lille, France
Institut Paoli Calmettes (IPC)
Marseille, France
Centre Hospitalier Universitaire (CHU) de Nice - Hopital L'Archet I
Nice, France
Centre Hospitalier Universitaire de Nimes (CHU) - Institut de Cancerologie du Gard
Nîmes, France
Publique-Hopitaux de Paris (AP-HP) - Hopital Saint-Louis
Paris, France
UNICANCER - Centre Henri-Becquerel
Rouen, France
Azienda Ospedaliero Universitaria Delle Marche
Ancona, Italy
Univerisity of Bologna Policlinico Sant'Orsola
Bologna, Italy
Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia
Brescia, Italy
Careggi University Hospital
Florence, Italy
Ospedale Vito Fazzi Lecce
Lecce, Italy
Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST S.r.l.
Meldola, Italy
ASST Grande Ospedale Metropolitano Niguarda
Milan, Italy
Azienda Ospedaliero Universitaria Pisana
Pisa, Italy
Azienda Ospedaliera Policlinico Universitario Tor Vergata
Roma, Italy
Humanitas Mirasole S.p.A.
Rozzano, Italy
Azienda Ospedaliera Universitaria Citta Della Salute E Della Scienza Di Torino
Turin, Italy
Wojewodzki Szpital Specjalistyczny w Bialej Podlaskiej
Biała Podlaska, Poland
Uniwersyteckie Centrum Kliniczne
Gdansk, Poland
Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy
Gliwice, Poland
Pratia Hematologia Sp. z o.o.
Katowice, Poland
Szpital Wojewodzki Im. Dr. Ludwika Rydygiera w Suwalkach
Suwałki, Poland
MICS Centrum Medyczne Toruń
Torun, Poland
Specjalistyczny Szpital Im. Dra Alfreda Sokolowskiego
Wałbrzych, Poland
Instytut Hematologii I Transfuzjologii
Warsaw, Poland
Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy
Warsaw, Poland
Dolnoslaskie Centrum Onkologii Pulmonologii i Hematologii
Wroclaw, Poland
Szpital Uniwersytecki Imienia Karola Marcinkowskiego w Zielonej Gorze Sp. z o. o.
Zielona Góra, Poland
MTZ Clinical Research
Warsaw, Mazowieckie Województwo, Poland
Hospital de la Santa Creu i de Sant Pau
Barcelona, Spain
Hospital del Mar
Barcelona, Spain
Institut Catala d'Oncologia Hospitalet
Barcelona, Spain
Complejo Hospitalario De Caceres - Hospital General San Pedro De Alcantara
Cáceres, Spain
Hospital Universitario La Paz (HULP)
Madrid, Spain
MD Anderson Cancer Center Madrid
Madrid, Spain
Hospital Regional Universitario de Málaga
Málaga, Spain
Clinica Universidad de Navarra
Pamplona, Spain
Virgen del Rocío University Hospital
Seville, Spain
Showing 40 of 41 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.